Experienced clinical research professional and nurse. Working with a network of clinical trial sites to deliver innovative & regionally relevant clinical trials to our local communities. Collaborating with all industry stakeholders to forge a future where innovative treatments, therapies and trials are accessible for all.

Bridget Barber is an Infectious Diseases Physician at Royal Brisbane & Women's Hospital, NHMRC Emerging Leadership Fellow, and Head of the Clinical Malaria Group at QIMR Berghofer Medical Research Institute. She has over 20 years' experience in clinical malaria research, and at QIMR now leads a team in conducting malaria volunteer infection studies.

Chief Executive Officer for Doherty Clinical Trials. We are a fully independent NFP subsidiary of The University of Melbourne. The Peter Doherty Institute for Infection and Immunity has established Doherty Clinical Trials Ltd, to deliver innovative early phase and human challenge clinical studies of the highest quality. We conduct typical early phase healthy volunteer studies in our 25-bed containment unit, including vaccine studies. Additionally, our facility is the only unit in Australia specifically commissioned to conduct human challenge trials. Doherty Clinical Trials is dedicated to delivering innovative, safe and ethically-sound trials in a range of therapeutic areas, including infectious diseases. Prior experience: - Twenty years pharmaceutical and research experience. Includes development lead and oversight of Phase I to Phase IV, sponsored and collaborative research trials, paediatric and adult studies. - Held several strategic & leadership roles in pharma (local and global), clinical research organization (CRO), and phase 1 unit. - >12 years’ experience in direct vaccine clinical research with pharma, including global roles (based in Europe) leading worldwide operational teams for diseases of developing world portfolio (malaria, tuberculosis and HIV vaccine development). - Head of Business Development, ANZ in a global CRO. Significant success in driving new business growth, strategic partnerships, and combining R&D and commercial delivery Experience working with external and philanthropic organisations to progress development of novel medicines. - Board Director for fara (Friedreich Ataxia Research Association), a not-for-profit patient advocacy organization that supports research into treatments and a cure for Friedreich Ataxia